Showing results (91-100 of 132) with videos related to
Sort By:
Pageof 14
Diagnostic Microbiology and Infectious Disease|January 24, 2006
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Ronald N Jones, Matthew G Stilwell, Helio S Sader, et al.The Journal of Antimicrobial Chemotherapy|June 11, 2004
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsRonald N Jones, Holly K Huynh, Douglas J Biedenbach, et al.International Journal of Systematic and Evolutionary Microbiology|September 17, 2005
'Candidatus Protochlamydia amoebophila', an endosymbiont of Acanthamoeba sppAstrid Collingro, Elena R Toenshoff, Michael W Taylor, et al.Diagnostic Microbiology and Infectious Disease|March 21, 2007
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance programLalitagauri M Deshpande, Thomas R Fritsche, Gary J Moet, et al.Journal of Clinical Microbiology|January 12, 2007
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United StatesDouglas J Biedenbach, James E Ross, Thomas R Fritsche, et al.The Journal of Antimicrobial Chemotherapy|November 27, 2004
Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Shawn A Messer, Jeffrey T Kirby, Helio S Sader, et al.International Journal of Antimicrobial Agents|May 2, 2006
Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003)Jennifer M Streit, Ronald N Jones, Mark A Toleman, et al.International Journal of Antimicrobial Agents|June 22, 2005
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) ProgramTamara R Anderegg, Helio S Sader, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|August 18, 2005
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continentsHelio S Sader, Ronald N Jones, Matthew G Stilwell, et al.Diagnostic Microbiology and Infectious Disease|August 18, 2005
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumoniaThomas R Fritsche, Helio S Sader, Matthew G Stilwell, et al.Pageof 14